Aging is a key risk factor in neurodegenerative disease; however, little is known about cellular pathways that mediate age-associated degeneration of the brain. The Bonini lab has identified a conserved microRNA, miR-34, that plays a neuroprotective role in the aging Drosophila brain and suggests that it functions in temporal control of gene expression.
Fact and folklore across cultures tell of our obsession with the pursuit of longevity. Thanks to medical advances and preventative care, average human lifespan has greatly increased over the past few decades. Further progress can be anticipated as we come to better understand the molecular and cellular underpinnings of aging 1,2. In this context, age-progressive neurodegenerative disorders that impair cognitive, sensory and motor functions pose a growing challenge.
Neurodegenerative diseases are characterized by the progressive loss of function of specific subsets of brain cells, and aging is a key risk factor of disease onset 3. In recent years microRNAs have come to attention for their roles in neurodegenerative diseases. MicroRNAs (miRNAs) are short non-coding RNAs that control the expression of protein-encoding messenger RNAs. Changes in the levels of some miRNAs have been observed in brain tissue from patients with neurodegenerative diseases 4,5. Using genetic models, miRNAs have been linked to neuronal function 6,7 and cell survival 5,8,9. miRNAs have also been linked to accumulation of the disease-related proteins α-synuclein and Ataxin1 10,11. These studies have suggested that exploring the functions of microRNAs and their targets could provide new insights into mechanisms that influence healthy and disease-related aging of the brain.
In a recent report, Liu et al. 12 show that a conserved microRNA, miR-34, has a neuroprotective role. In the absence of miR-34, flies show early-onset movement disorder associated with age-progressive loss of neurons. The Bonini lab had previously reported that blocking microRNA biogenesis enhanced poly-Q-induced neural degeneration 8. Even without PolyQ expression to sensitize the system, Liu et al. now find that miRNA-deficient animals had shortened lifespan and exhibited early-onset neurodegeneration. They examined age-dependent changes in miRNA expression and found that miR-34 was upregulated in older brains. Mutants for miR-34 showed a severe age-progressive form of movement disorder compared to age-matched controls. Interestingly, young flies were unaffected by the absence of miR-34. Defects became apparent with age and progressively worsened, culminating in early death. Behavioral impairment was accompanied by premature neural degeneration. To explore this process in more depth, the authors took a genome-wide approach to identify molecular correlates of aging. By transcriptional profiling they identified 173 genes whose expression correlated with normal brain aging. A majority of the upregulated genes showed a premature increase with age in miR-34 mutants. The picture that emerges from these studies suggests accelerated brain aging in the mutant.
miRNAs function by guiding ribonucleoprotein complexes to target mRNAs, leading to transcript destabilization and/or translational repression. Target prediction algorithms typically predict hundreds of candidate targets. Targetscan predicts 98 targets for miR-34 (www.targetscan.org). For reasons unspecified, Liu et al. focused on one of these, Eip74EF, which encodes a transcription factor regulated by the steroid hormone ecdysone. Interestingly, they observed that expression of the E74A protein isoform encoded by Eip74EF showed a reciprocal pattern of temporal expression to miR-34. E74A protein expression was high in young flies, when miR-34 expression was low. Reciprocally, E74A levels were low in later life when miR-34 levels increased. In miR-34 mutants, E74A protein levels were increased.
The authors next tackled the question of whether the elevated levels of E74A that occur in the mutant are responsible for the degenerative and behavioral defects. If this were the case, downregulation of E74A in the mutant would be predicted to rescue these deficits, whereas overexpression of E74A would be predicted to mimic the loss of miR-34. Both predictions were validated, showing that too much E74A is detrimental. The rising level of miR-34 miRNA contributes to lowering the levels of its target in the aging brain. Failure to do so has severe consequences.
The appearance of misfolded protein aggregates in the brain is characteristic of neurodegenerative diseases 13. Interestingly, loss of miR-34 also resulted in an increase in the number of brain inclusions. The Bonini lab had previously shown that expression of bantam microRNA could suppress neurodegeneration induced by the ataxin-3 polyglutamine (PolyQ) disease protein without affecting the formation of protein inclusions 8. In the case of miR-34, they found that the miRNA was able to slow the formation of PolyQ inclusions. It would be interesting to know whether the upregulation of E74A in the miR-34 mutants contributed to the formation of the PolyQ inclusions. This would strengthen the link between inclusion formation, brain vacuolization and the other age-related defects of miR-34. Finally, since miR-34 appeared to have age-dependent neuroprotective functions, the authors asked whether upregulation of miR-34 could enhance lifespan. This proved to be the case.
Bonini and colleagues present the intriguing suggestion that the role of an adult-expressed miRNA, such as miR-34, may be to repress developmental genes such as E74A whose later expression is harmful to the organism. This notion of temporal reciprocity is a variation on the spatial reciprocity model in which miRNAs have been proposed to limit spatial expression of targets that would be harmful if expressed in the miRNA-expressing cells 14. Temporal reciprocity between miRNAs and targets has also been observed during the dramatic changes in gene expression that occur during the mid-blastula transition in the fly embryo 15. The observation that miRNAs confer reciprocity is interesting, but it begs the question of why use miRNAs instead of transcriptional repression or epigenetic silencing mechanisms? Tissue repair in response to injury may require cells to maintain a level of developmental plasticity. They can do this via epigenetic reprogramming, but a more reversible state mediated by miRNAs could offer advantages.
The identification of age-associated roles for miR-34 raises the question of what aging-related signal regulates its function. One candidate is the currently controversial family of sirtuins, which has been shown to regulate control of neuronal function via a miRNA-based mechanism 6.
In light of its neuroprotective roles and its relevance to aging, the evolutionary conservation of miR-34 is tantalizing. Unfortunately the molecular mechanism reported in this study does not suggest a conserved microRNA-target relationship. Yet, the changes in miRNA and target gene expression provide a molecular signature of the aging brain. Comparing aging data from transcriptional profiling of different species to try to identify conserved pathways might point to the way to disease-relevant processes in humans 2,3. Taking the long view, we can look forward to turning our understanding of the fundamental mechanisms of brain aging into new approaches to managing neurodegenerative disease.
Kenyon CJ . The genetics of ageing. Nature 2010; 464:504–512.
Slagboom PE, Beekman M, Passtoors WM, et al. Genomics of human longevity. Philos Trans R Soc Lond B Biol Sci 2011; 366:35–42.
Bishop NA, Lu T, Yankner BA . Neural mechanisms of ageing and cognitive decline. Nature 2010; 464:529–535.
Hébert SS, Horré K, Nicolaï L, et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci USA 2008; 105:6415–6420.
Kim J, Inoue K, Ishii J, et al. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 2007; 317:1220–1224.
Gao J, Wang WY, Mao YW, et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 2010; 466:1105–1109.
Edbauer D, Neilson JR, Foster KA, et al. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 2010; 65:373–384.
Bilen J, Liu N, Burnett BG, Pittman RN, Bonini NM . MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Mol Cell 2006; 24:157–163.
Karres JS, Hilgers V, Carrera I, Treisman J, Cohen SM . The conserved microRNA miR-8 tunes atrophin levels to prevent neurodegeneration in Drosophila. Cell 2007; 131:136–145.
Wang G, van der Walt JM, Mayhew G, et al. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet 2008; 82:283–289
Lee Y, Samaco RC, Gatchel JR, Thaller C, Orr HT, Zoghbi HY . miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat Neurosci 2008; 11:1137–1139.
Liu N, Landreh M, Cao K, et al. The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature 2012; 482:519–523.
Jucker M, Walker LC . Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 2011; 70:532–540.
Stark A, Brennecke J, Bushati N, Russell RB, Cohen SM . Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3′UTR evolution. Cell 2005; 123:1133–1146.
Bushati N, Stark A, Brennecke J, Cohen SM . Temporal reciprocity of miRNAs and their targets during the maternal-to-zygotic transition in Drosophila. Curr Biol 2008; 18:501–506.
About this article
Cite this article
Aw, S., Cohen, S. Time is of the essence: microRNAs and age-associated neurodegeneration. Cell Res 22, 1218–1220 (2012). https://doi.org/10.1038/cr.2012.59